Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry

Occupational and Environmental Medicine

Volumn 68, Issue 11, 2011, Pages 842-848

  Van Dyke, Michael V ^a,b   Martyny, John W ^a,b,c   Mroz, Margaret M ^a   Silveira, Lori J ^a   Strand, Matt ^a   Cragle, Donna L ^d   Tankersley, William G ^d   Wells, Susan M ^d   Newman, Lee S ^c   Maier, Lisa A ^a,c  

^a DEPARTMENT OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d OAK RIDGE ASSOCIATED UNIVERSITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; HLA DP ANTIGEN; HLA DP BETA 69 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ATOMIC BOMB; BERYLLIUM SENSITIZATION; CHRONIC BERYLLIUM DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ANALYSIS; GENOTYPE; HEAVY METAL POISONING; HUMAN; HYGIENE; INTERVIEW; MAJOR CLINICAL STUDY; MALE; METAL INDUSTRY; OCCUPATIONAL EXPOSURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BERYLLIOSIS; BERYLLIUM; CASE-CONTROL STUDIES; FEMALE; HLA-DP BETA-CHAINS; HUMANS; INDUSTRY; MALE; MIDDLE AGED; NUCLEAR WEAPONS; OCCUPATIONAL EXPOSURE; RISK FACTORS;

EID: 80053907540     PISSN: 13510711     EISSN: 14707926     Source Type: Journal    
DOI: 10.1136/oem.2010.064220     Document Type: Article

References (39)

1. Rosenman K, Hertzberg V, Rice C, et al. Chronic beryllium disease and sensitization at a beryllium processing facility. Environ Health Perspect 2005;113:1366-72. (Pubitemid 41511994)
2. Kreiss K, Newman LS, Mroz MM, et al. Screening blood test identifies subclinical beryllium disease. J Occup Med 1989;31:603-8. (Pubitemid 19179743)
3. Stanton ML, Henneberger PK, Kent MS, et al. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers. J Occup Environ Med 2006;48:204-11. (Pubitemid 43239594)
4. Kreiss K, Mroz MM, Newman LS, et al. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3. Am J Ind Med 1996;30:16-25. (Pubitemid 26279451)
5. Kreiss K, Mroz MM, Zhen B, et al. Epidemiology of beryllium sensitization and disease in nuclear workers. Am Rev Respir Dis 1993;148:985-91. (Pubitemid 23301218)
6. Stefaniak AB, Hoover MD, Day GA, et al. Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease. J Environ Monit 2004;6:523-32. (Pubitemid 38869579)
7. Kent MS, Robins TG, Madl AK. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility. Appl Occup Environ Hyg 2001;16:539-58. (Pubitemid 32428738)
8. Martyny JW, Hoover MD, Mroz MM, et al. Aerosols generated during beryllium machining. J Occup Environ Med 2000;42:8-18. (Pubitemid 30062745)
9. Kelleher PC, Martyny JW, Mroz MM, et al. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med 2001;43:238-49. (Pubitemid 32238503)
10. Virji MA, Stefaniak AB, Day GA, et al. Characteristics of beryllium exposure to small particles at a beryllium production facility. Ann Occup Hyg 2011;55:70-85.
11. Tinkle SS, Antonini JM, Rich BA, et al. Skin as a route of exposure and sensitization in chronic beryllium disease. Environ Health Perspect 2003;111:1202-8. (Pubitemid 36939402)
12. Day GA, Stefaniak AB, Weston A, et al. Beryllium exposure: dermal and immunological considerations. Int Arch Occup Environ Health 2006;79:161-4. (Pubitemid 43008887)
13. Stefaniak AB, Virji MA, Day GA. Release of beryllium from beryllium-containing materials in artificial skin surface film liquids. Ann Occup Hyg 2011;55:57-69.
14. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993;262:242-4. (Pubitemid 23344468)
15. Richeldi L, Kreiss K, Mroz MM, et al. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 1997;32:337-40. (Pubitemid 27330274)
16. Wang Z, White PS, Petrovic M, et al. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol 1999;163:1647-53. (Pubitemid 29352790)
17. Saltini C, Richeldi L, Losi M, et al. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 2001;18:677-84. (Pubitemid 33040628)
18. Rossman MD, Stubbs J, Lee CW, et al. Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 2002;165:788-94. (Pubitemid 34229648)
19. Maier LA, McGrath DS, Sato H, et al. Influence of MHC CLASS II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 2003;171:6910-18. (Pubitemid 37532127)
20. McCanlies EC, Ensey JS, Schuler CR, et al. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 2004;46:95-103. (Pubitemid 39062615)
21. Wang Z, Farris GM, Newman LS, et al. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology 2001;165:27-38. (Pubitemid 32718695)
22. Rosenman KD, Rossman M, Hertzberg V, et al. HLA class II DPB1 and DRB1 polymorphisms associated with genetic susceptibility to beryllium toxicity. Occup Environ Med 2011;68:487-93.
23. Welsh K, Bunce M. Molecular typing for the MHC with PCR-SSP. Rev Immunogenet 1999;1:157-76.
24. Snyder JA, Demchuk E, McCanlies EC, et al. Impact of negatively charged patches on the surface of MHC class II antigen-presenting proteins on risk of chronic beryllium disease. J R Soc Interface 2008;5:749-58. (Pubitemid 351882141)
25. Snyder JA, Weston A, Tinkle SS, et al. Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease. Environ Health Perspect 2003;111:1827-34. (Pubitemid 37526963)
26. Fontenot AP, Torres M, Marshall WH, et al. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc Natl Acad Sci U S A 2000;97:12717-22.
27. Demidenko E. Sample size and optimal design for logistic regression with binary interaction. Stat Med 2008;27:36-46. (Pubitemid 351193658)
28. Viet SM, Torma-Krajewski J, Rogers J. Chronic beryllium disease and beryllium sensitization at Rocky Flats: a case-control study. Am Ind Hyg Assoc J 2000;61:244-54. (Pubitemid 30217786)
29. Kreiss K, Wasserman S, Mroz MM, et al. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J Occup Med 1993;35:267-74. (Pubitemid 23084157)
30. Stange AW, Furman FJ, Hilmas DE. Rocky flats beryllium health surveillance. Environ Health Perspect 1996;104S:981-6. (Pubitemid 26402341)
31. Welch L, Ringen K, Bingham E, et al. Screening for beryllium disease among construction trade workers at Department of Energy nuclear sites. Am J Ind Med 2004;46:207-18. (Pubitemid 39180816)
32. Schuler CR, Kent MS, Deubner DC, et al. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility. Am J Ind Med 2005;47:195-205. (Pubitemid 40326251)
33. Cummings KJ, Deubner DC, Day GA, et al. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers. Occup Environ Med 2007;64:134-40.
34. Henneberger PK, Cumro D, Deubner DD, et al. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant. Int Arch Occup Environ Health 2001;74:167-76. (Pubitemid 32377453)
35. Kreiss K, Mroz MM, Zhen B, et al. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant. Occup Environ Med 1997;54:605-12. (Pubitemid 27374989)
36. Joffe M. Validity of exposure data derived from a structured questionnaire. Am J Epidemiol 1992;135:564-70.
37. Blair A, Zahm SH. Patterns of pesticide use among farmers: implications for epidemiologic research. Epidemiology 1993;4:55-62. (Pubitemid 23070118)
38. Fritschi L, Siemiatycki J, Richardson L. Self-assessed versus expert-assessed occupational exposures. Am J Epidemiol 1996;144:521-7. (Pubitemid 26296136)
39. Nordstrom DL, Vierkant RA, Layde PM, et al. Comparison of self-reported and expert-observed physical activities at work in a general population. Am J Ind Med 1998;34:29-35. (Pubitemid 28240777)